Phase 2 HIT Clinical Trials
15 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–15 of 15 trials
Recruiting
Phase 2
the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer
Breast CancerNeutropenia (Low White Blood Cell Count)Leucogen+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University94 enrolled1 locationNCT07380646
Recruiting
Phase 2
CLF065 for Chronic Pouchitis
Pouchitis
Calibr, a division of Scripps Research20 enrolled1 locationNCT07226050
Recruiting
Phase 2
Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
Blasts More Than 5 Percent of Bone Marrow Nucleated CellsChronic Eosinophilic Leukemia-not Otherwise SpecifiedBCR-JAK2 Fusion Protein Expression+9 more
William Shomali10 enrolled4 locationsNCT03801434
Recruiting
Phase 1Phase 2
An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
Vanishing White Matter Disease
Calico Life Sciences LLC50 enrolled5 locationsNCT05757141
Recruiting
Phase 2
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
Acute Myeloid LeukemiaMyelodysplastic SyndromeBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive+11 more
M.D. Anderson Cancer Center508 enrolled1 locationNCT02115295
Recruiting
Phase 1Phase 2
Retina is a Marker for Cerebrovascular Heath
Cerebral Small Vessel DiseasesCerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and LeukoencephalopathyCerebral Microbleeding+1 more
Mayo Clinic100 enrolled1 locationNCT04753970
Recruiting
Phase 1Phase 2
A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies
Chronic Lymphocytic Leukemia (CLL)High Grade B-Cell Lymphoma, Not Otherwise SpecifiedMultiple Myeloma (MM)+3 more
IDP Discovery Pharma S.L.37 enrolled11 locationsNCT05908409
Recruiting
Phase 2
Fecal Microbiota Transplantation for Pouchitis
Pouchitis
McMaster University34 enrolled1 locationNCT03545386
Recruiting
Phase 2
Topical 10% Povidone-Iodine in Preventing White Spots
White spot lesionsGingival Inflammation and Bleeding
University of Washington80 enrolled1 locationNCT06616207
Recruiting
Phase 2
Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD
COPDCOPD ExacerbationImmune System Disorder+2 more
Asger Sverrild80 enrolled2 locationsNCT05507242
Recruiting
Phase 2
Biological Effects of Quercetin in COPD Phase II
Chronic Obstructive Pulmonary DiseaseEmphysemaChronic Bronchitis With Airway Obstruction
Temple University30 enrolled1 locationNCT06003270
Not Yet Recruiting
Phase 2
The Effect of a Probiotic To Improve Ileal Pouch Health: A Randomised Controlled Trial
Pouchitis following ileal pouch formation due to colorectal resection
University of Otago155 enrolled1 locationACTRN12619000895189
Not Yet Recruiting
Phase 2
The effect of chitosan spray on bleeding and wound healing following tear duct surgery.
To evaluate the effect of topical chitosan spray on haemostasis and wound healing following endoscopic dacryocystorhinostomy (endoDCR) without intubation.
South Australian Institute of Ophthalmology26 enrolled1 locationACTRN12609001028291
Completed
Phase 2
An oral killed non-typeable Haemophilus influenzae vaccine for preventing episodes of acute bronchitis in patients with mild to moderate airways disease: Safety and efficacy study
Acute bronchitis in mild to moderate airway disease
Hunter Immunology Ltd124 enrolled1 locationACTRN12606000076572
Completed
Phase 2
An oral killed Non-typeable Haemophilus influenzae vaccine for preventing episodes of acute bronchitis in patients with moderate to severe airways disease: Safety and efficacy study
Acute bronchitis in moderate to severe airway disease
Hunter Immunology Ltd124 enrolled1 locationACTRN12606000074594